{"Eighteen": [0], "nucleic": [1, 157], "acid": [2, 158], "therapeutics": [3, 85], "have": [4, 170], "been": [5], "approved": [6], "for": [7], "treatment": [8], "of": [9, 19, 46, 72, 82, 95, 150, 167, 181, 188, 191], "various": [10], "diseases": [11, 40], "in": [12, 130, 156, 161], "the": [13, 39, 106, 123, 172, 189], "last": [14], "25": [15], "years.": [16], "Their": [17], "modes": [18], "action": [20], "include": [21], "antisense": [22], "oligonucleotides": [23, 26, 132, 169], "(ASOs),": [24], "splice-switching": [25], "(SSOs),": [27], "RNA": [28, 33, 75, 104], "interference": [29], "(RNAi)": [30], "and": [31, 67, 74, 97, 105, 122, 139, 142, 153, 164, 177], "an": [32, 186], "aptamer": [34], "against": [35], "a": [36, 93, 148], "protein.": [37], "Among": [38], "targeted": [41, 192], "by": [42], "this": [43, 145], "new": [44], "class": [45], "drugs": [47, 80], "are": [48, 119], "homozygous": [49], "familial": [50, 61], "hypercholesterolemia,": [51], "spinal": [52], "muscular": [53, 56], "atrophy,": [54], "Duchenne": [55], "dystrophy,": [57], "hereditary": [58], "transthyretin-mediated": [59], "amyloidosis,": [60], "chylomicronemia": [62], "syndrome,": [63], "acute": [64], "hepatic": [65], "porphyria,": [66], "primary": [68], "hyperoxaluria.": [69], "Chemical": [70], "modification": [71], "DNA": [73], "was": [76], "central": [77], "to": [78, 87, 174, 195], "making": [79], "out": [81], "oligonucleotides.": [83], "Oligonucleotide": [84], "brought": [86], "market": [88], "thus": [89], "far": [90], "contain": [91], "just": [92], "handful": [94], "first-": [96], "second-generation": [98], "modifications,": [99], "among": [100], "them": [101], "2'-fluoro-RNA,": [102], "2'-O-methyl": [103], "phosphorothioates": [107], "that": [108], "were": [109], "introduced": [110], "over": [111], "50": [112], "years": [113], "ago.": [114], "Two": [115], "other": [116], "privileged": [117], "chemistries": [118, 152], "2'-O-(2-methoxyethyl)-RNA": [120], "(MOE)": [121], "phosphorodiamidate": [124], "morpholinos": [125], "(PMO).": [126], "Given": [127], "their": [128, 154], "importance": [129], "imparting": [131], "with": [133], "high": [134], "target": [135], "affinity,": [136], "metabolic": [137], "stability": [138], "favorable": [140], "pharmacokinetic": [141], "-dynamic": [143], "properties,": [144], "article": [146], "provides": [147, 185], "review": [149, 184], "these": [151], "use": [155], "therapeutics.": [159], "Breakthroughs": [160], "lipid": [162], "formulation": [163], "GalNAc": [165], "conjugation": [166], "modified": [168], "paved": [171], "way": [173], "efficient": [175], "delivery": [176, 194], "robust,": [178], "long-lasting": [179], "silencing": [180], "genes.": [182], "This": [183], "account": [187], "state-of-the-art": [190], "oligo": [193], "hepatocytes.": [196]}